8月6日 - ** 疫苗生产商 Novavax NVAX.O 股价盘前上涨 3.57% 至 7 美元
** 该公司公布的 (link) 第二季度收入为 2.39 亿美元，分析师预计为 1.4796 亿美元。
** 公司称，因其 COVID-19 疫苗在美国获批，公司获得了 1.75 亿美元的里程碑付款。
** 公司目前预计全年调整后总收入在 10 亿至 10.5 亿美元之间，而之前的预期为 9.75 亿至 10.3 亿美元
** 第二季度净收入为 1.065 亿美元，低于去年同期的 1.624 亿美元
** 截至上次收盘，股价累计下跌 16
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.